Advertisement
Screener

VIATRIS INC. (VTRS) Debt / Equity

VIATRIS INC. (VTRS) Debt / Equity

  • 2026-06-30: Debt/Equity Ratio 0.94.
  • 2026-03-31: Debt/Equity Ratio 0.98.
  • 2025-12-31: Debt/Equity Ratio 0.98.
  • 2025-09-30: Debt/Equity Ratio 0.95.

Complete source-backed debt/equity ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-300.94
2026-03-310.98
2025-12-310.98
2025-09-300.95
2025-06-300.93
2025-03-310.91
2024-12-310.75
2024-09-300.8
2024-06-300.88
2024-03-310.9
2023-12-310.89
2023-09-300.88
2023-06-300.89
2023-03-310.89
2022-12-310.91
2022-09-301.02
2022-06-301.01
2022-03-311.05
2021-12-311.05
2021-09-301.03
2021-06-301.09
2021-03-311.14
2020-12-311.08

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-310.98
2024-12-310.75
2023-12-310.89
2022-12-310.91
2021-12-311.05
2020-12-311.08

Similar stocks

Stock NameCountryMarket CapPE Ratio
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17